An intragenic deletion of the P gene is the common mutation causing tyrosinase-positive oculocutaneous albinism in southern African Negroids
- PMID: 7887411
- PMCID: PMC1801183
An intragenic deletion of the P gene is the common mutation causing tyrosinase-positive oculocutaneous albinism in southern African Negroids
Abstract
Tyrosinase-positive oculocutaneous albinism (OCA2), an autosomal recessive disorder of the melanin biosynthetic pathway, is the most common recessive disorder occurring in southern African Bantu-speaking Negroids, with an overall prevalence of 1/3,900. The OCA2 gene, P, has been mapped to chromosome 15q11-q13, and recently alterations in the P gene have been identified in OCA2 individuals. An intragenic deletion has been described and proposed to be of African origin because of its occurrence in four unrelated African American OCA2 individuals and in two individuals, one from Zaire and the other from Cameroon. This study shows that the intragenic deletion is a common cause of OCA2 in southern African Negroids (114/146 [.78]; OCA2 chromosomes) and is associated with one common haplotype (43/55 [.78]; OCA2 chromosomes), confirming the African origin of this allele. On the basis of haplotype data, it would appear that at least seven additional, less frequent OCA2 mutations occur in this population.
Similar articles
-
African origin of an intragenic deletion of the human P gene in tyrosinase positive oculocutaneous albinism.Nat Genet. 1994 Jun;7(2):176-9. doi: 10.1038/ng0694-176. Nat Genet. 1994. PMID: 7920637
-
Diverse mutations of the P gene among African-Americans with type II (tyrosinase-positive) oculocutaneous albinism (OCA2).Hum Mol Genet. 1994 Nov;3(11):2047-51. Hum Mol Genet. 1994. PMID: 7874125
-
Oculocutaneous albinism (OCA2) in sub-Saharan Africa: distribution of the common 2.7-kb P gene deletion mutation.Hum Genet. 1997 Apr;99(4):523-7. doi: 10.1007/s004390050400. Hum Genet. 1997. PMID: 9099845
-
The pink-eyed dilution gene and the molecular pathogenesis of tyrosinase-positive albinism (OCA2).J Dermatol. 1999 Nov;26(11):738-47. doi: 10.1111/j.1346-8138.1999.tb02085.x. J Dermatol. 1999. PMID: 10635616 Review. No abstract available.
-
[Human oculocutaneous albinism. From clinical observation to molecular biology].Bull Soc Pathol Exot. 1993;86(5):313-26. Bull Soc Pathol Exot. 1993. PMID: 8124097 Review. French.
Cited by
-
Distribution of oculocutaneous albinism in Zimbabwe.J Med Genet. 1996 Aug;33(8):641-4. doi: 10.1136/jmg.33.8.641. J Med Genet. 1996. PMID: 8863154 Free PMC article.
-
Two cases of burns in children from French Guinea with oculocutaneous albinism.Ann Burns Fire Disasters. 2010 Sep 30;23(3):146-50. Ann Burns Fire Disasters. 2010. PMID: 21991215 Free PMC article.
-
Albinism research in a Southern African setting: unique findings.J Community Genet. 2025 Apr;16(2):107-116. doi: 10.1007/s12687-025-00786-3. Epub 2025 Mar 26. J Community Genet. 2025. PMID: 40138079 Free PMC article. Review.
-
Oculocutaneous albinism in southern Africa: Historical background, genetic, clinical and psychosocial issues.Afr J Disabil. 2022 Oct 14;11:877. doi: 10.4102/ajod.v11i0.877. eCollection 2022. Afr J Disabil. 2022. PMID: 36353393 Free PMC article.
-
Genetic testing for oculocutaneous albinism type 1 and 2 and Hermansky-Pudlak syndrome type 1 and 3 mutations in Puerto Rico.J Invest Dermatol. 2006 Jan;126(1):85-90. doi: 10.1038/sj.jid.5700034. J Invest Dermatol. 2006. PMID: 16417222 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources